Actinium Pharmaceuticals Inc

Closed

0.97

Overview

Share price change

24h

Current

Min

0.96

Max

0.98

Key metrics

By Trading Economics

Income

418K

-5.5M

EPS

-0.18

Profit margin

-6,600

Employees

25

EBITDA

906K

-5.3M

Recommendations

By TipRanks

Recommendations

Buy

12 Months Forecast

+359.18% upside

Dividends

By Acuity

Next Earnings

6 Aug 2026

Market Stats

By TradingEconomics

Market Cap

-6.6M

31M

Previous open

0.97

Previous close

0.97

Actinium Pharmaceuticals Inc Chart

Past performance is not a reliable indicator of future results.

Related News

2 Jul 2026, 23:56 UTC

Macro News

FTSE 100 Index rises in after-market hours as inflation concerns ease. Positive corporate news and U.S. employment data support the upward momentum.

2 Jul 2026, 23:56 UTC

Correlated Moves

EUR/TRY is higher in Thursday's session, supported by a modest increase since Wednesday's close. The pair remains volatile within its one-month range.

2 Jul 2026, 23:56 UTC

ETF Constituents

The Vanguard FTSE Emerging Markets ETF was little changed in after-market hours, with INFY, TCOM, and JD contributing slight declines.

2 Jul 2026, 23:51 UTC

Asia equity markets decline amid semiconductor sell-off, while U.S. indices rise on weak job data easing rate hike fears; European markets gain as defensive sectors lead.

2 Jul 2026, 23:51 UTC

U.S. job growth disappoints with only 57k added in June, prompting reassessment of Fed rate hike expectations, while global markets show mixed signals amid easing inflation concerns.

2 Jul 2026, 23:51 UTC

US equity indices rise as lower-than-expected job growth eases interest rate hike fears, while European markets gain and Asian stocks face losses.

2 Jul 2026, 23:51 UTC

European equity markets rise on positive economic data and easing inflation, with Germany's DAX up 1.9% and Italy's unemployment hitting a record low of 5.0%.

2 Jul 2026, 23:51 UTC

Mexico's Inflation Rate Release on July 9, 2026: Market Eyes Rising Trends Amid Tariff and Oil Price Concerns.

2 Jul 2026, 23:51 UTC

Mexican Inflation Rate Expected to Decline Further Ahead of July 9 Release, Influencing Market Sentiment Amid Global Trends.

2 Jul 2026, 23:51 UTC

Social Media

Fox Corp shares are lower in after-market hours despite record viewership for the U.S. Men's National Team match, averaging 24.43 million viewers.

2 Jul 2026, 23:51 UTC

Fiserv Inc. shares are higher in after-market trading, reflecting positive sentiment following weaker-than-expected job growth data that has eased rate hike concerns.

2 Jul 2026, 23:51 UTC

Macro News
Social Media
ETF Constituents
Correlated Moves

The KOSPI index fell sharply, impacting the iShares MSCI South Korea ETF, which remained near unchanged in after-hours trading.

2 Jul 2026, 23:51 UTC

Lam Research Corp shares are higher in after-market trading, reflecting positive sentiment following a weaker-than-expected jobs report and tempered rate hike fears.

2 Jul 2026, 23:51 UTC

Terra is trading higher today, continuing its upward momentum since Wednesday's close. The asset remains below its 20-day moving average.

2 Jul 2026, 23:51 UTC

PepsiCo Inc shares are lower in after-market hours, with no specific news identified to explain the decline amid generally positive broader market sentiment.

2 Jul 2026, 23:46 UTC

Correlated Moves

J B Hunt Transport Services Inc shares are higher in after-market trading, following a modest increase since Thursday's close amid stable market conditions.

2 Jul 2026, 23:46 UTC

The iShares Core U.S. Aggregate Bond ETF is trading lower in after-market hours, reflecting a decline since Thursday's close and nearing its one-month low.

2 Jul 2026, 23:46 UTC

Macro News
ETF Constituents
Correlated Moves

Energy Select Sector SPDR Fund declines after-market, influenced by weak U.S. employment data and slight losses among major holdings like Exxon Mobil and Chevron.

2 Jul 2026, 23:42 UTC

U.S. Trade Deficit Expected to Widen to $78.8 Billion in May 2026 Amid Economic Uncertainties and Geopolitical Tensions

2 Jul 2026, 23:42 UTC

U.S. Exports Data Release on July 7 Expected to Reflect Mixed Performance Amid Global Economic Challenges and Tariff Changes

2 Jul 2026, 23:42 UTC

U.S. Imports Data Release on July 7, 2026, Expected to Reflect Strong Growth Amid Tariff Changes and Supply Chain Adjustments

2 Jul 2026, 23:42 UTC

Canada's Trade Surplus Expected to Continue Amid Geopolitical Tensions Ahead of July 7 Data Release

2 Jul 2026, 23:41 UTC

Correlated Moves

NXP Semiconductors NV shares are higher in after-market trading, reflecting a modest increase since Thursday's close amid gains in Skyworks Solutions Inc.

2 Jul 2026, 23:41 UTC

NetApp Inc shares are lower in after-market trading, with no specific news identified to explain the decline. The stock remains near its one-month trading range.

2 Jul 2026, 23:41 UTC

News
Social Media

Meta shares rise in after-market trading as CEO Zuckerberg highlights upcoming AI benefits and announces new application Pocket, despite some setbacks.

2 Jul 2026, 23:41 UTC

Macro News
Correlated Moves

Bitcoin reached a one-week high today, boosted by weaker U.S. employment data and optimism about Federal Reserve rate hikes. Related stocks also gained.

2 Jul 2026, 23:36 UTC

The US Dollar Index is trading roughly flat amid routine price action. European equity markets closed positively, driven by gains in defensive sectors and pharmaceuticals.

2 Jul 2026, 23:36 UTC

Correlated Moves
Macro News
ETF Constituents

The SPDR S&P Bank ETF is higher after hours, supported by Third Coast Bancshares' $30 million share repurchase program and mixed market performance.

2 Jul 2026, 23:36 UTC

Kraft Heinz Co shares are lower in after-market hours, with no specific news identified to explain the movement. The stock briefly reached a session high earlier.

2 Jul 2026, 23:32 UTC

News
Social Media

Microsoft launches AI initiative Microsoft Frontier Company with $2.5 billion backing. Shares are higher in after-market trading, continuing the broader software sector's upward trend.

Peer Comparison

Price change

Actinium Pharmaceuticals Inc Forecast

Price Target

By TipRanks

359.18% upside

12 Months Forecast

Average 4.5 USD  359.18%

High 5 USD

Low 4 USD

Based on 2 Wall Street analysts offering 12 month price targets forActinium Pharmaceuticals Inc - Dist in the last 3 months.

Rating Consensus

By TipRanks

Buy

2 ratings

2

Buy

0

Hold

0

Sell

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

$

About Actinium Pharmaceuticals Inc

Actinium Pharmaceuticals, Inc. develops antibody radiation conjugates and other targeted radiotherapies intended to improve outcomes for people who have failed existing oncology therapies. Its Iomab-B is an induction and conditioning agent prior to bone marrow transplant in patients with relapsed and refractory acute myeloid leukemia (r/r AML). The company focuses on advancing its development for product candidate Actimab-A, a therapeutic agent that has demonstrated potential activity in r/r AML patients. In addition, it engages with the National Cancer Institute under the cooperative research and development agreement for the development of Actimab-A in AML and other myeloid malignancies. Its Iomab-ACT, a next generation conditioning candidate, is being developed for improving patient access and outcomes for curative cell and gene therapies. Further, the company's research and development activities primarily focus on advancing various preclinical programs for solid tumor indications. The company holds approximately 235 patents and patent applications, including various patents related to the manufacture of the isotope Ac-225 in a cyclotron. The company is based in New York, New York.
help-icon Live chat